These findings suggest that the induction of T-cell apoptosis through inhibition of the TNFR2-mTNF-α pathway is one of the mechanisms by which anti-TNF agents control intestinal pathology in patients with IBD. The gene discussed is TNFRSF1B; the disease is inflammatory bowel disease.